BETNOVATE C

This brand name is authorized in New Zealand, Poland, Turkey

Active ingredients

The drug BETNOVATE C contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII 9IFA5XM7R2 - BETAMETHASONE VALERATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Clioquinol UNII 7BHQ856EJ5 - CLIOQUINOL

Read about Clioquinol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07BC01	Betamethasone and antiseptics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BC Corticosteroids, potent, combinations with antiseptics
Discover more medicines within D07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 175
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100087363, 100228295
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522350445, 8699522356331, 8699522359318, 8699522380459, 8699522386345, 8699522389322